These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 152571)

  • 1. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
    Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
    Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
    Stojan B
    Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of complement components C3 and factor B in synovial fluids.
    Hunder GG; McDuffie FC; Mullen BJ
    J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
    Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
    Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activated C3 in the synovial fluid of patients with rheumatoid arthritis and arthrosis (correlations with C3, C4 and C3 proactivator/modification caused by storage)].
    Hasler F; Stojan B
    Z Rheumatol; 1981; 40(1):40-3. PubMed ID: 6908792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations between inflammatory activity, immunoglobulins and complement components in the synovial fluid of patients with rheumatoid arthritis and arthrosis].
    Stojan B; Hasler F
    Schweiz Med Wochenschr; 1978 Jul; 108(30):1165-8. PubMed ID: 675210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of serum complement (C3 and C4) in inflammatory joint diseases].
    Dacheva V; Dimov DM; Nedialkova V; Koleva P
    Vutr Boles; 1990; 29(5):68-74. PubMed ID: 1706901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 cleavage product in synovial fluids detected by immunofixation.
    Partsch G; Bauer K; Bröll H; Petera P; Dunky A; Merétey K
    Z Rheumatol; 1991; 50(2):82-5. PubMed ID: 1872046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
    Hasselbacher P
    Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of synovial fluid total hemolytic complement activity.
    Kim HJ; McCarty DJ; Kozin F; Koethe S
    J Rheumatol; 1980; 7(2):143-52. PubMed ID: 7373616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-2-microglobulin and rheumatic diseases (author's transl)].
    Manicourt D
    Acta Rhumatol; 1979; 3(1):13-28. PubMed ID: 92177
    [No Abstract]   [Full Text] [Related]  

  • 17. The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.
    Hedberg H; Laurell AB
    Clin Exp Immunol; 1972 Jun; 11(2):201-7. PubMed ID: 5040309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseases.
    March RE; Reeback JS; Holborow EJ; Jones VE; Jacoby RK
    Clin Exp Immunol; 1982 Jun; 48(3):555-60. PubMed ID: 6981473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
    Stojan B; Hasler F
    Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B
    Z Rheumatol; 1976; 35(7-8):272-7. PubMed ID: 961078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.